Gonzalez-Valdes I, Hidalgo I, Bujarrabal A, Lara-Pezzi E, Padron-Barthe L, Garcia-Pavia P, Gómez-del Arco P, Redondo J M, Ruiz-Cabello J M, Jimenez-Borreguero L J, Enriquez J A, de la Pompa J L, Hidalgo A, Gonzalez S
Stem Cell Aging Group, Centro Nacional de Investigaciones Cardiovasculares (CNIC), E-28029 Madrid, Spain.
Molecular Regulation of Heart Development and Disease Group, Centro Nacional de Investigaciones Cardiovasculares (CNIC), E-28029 Madrid, Spain.
Nat Commun. 2015 Mar 9;6:6473. doi: 10.1038/ncomms7473.
Dilated cardiomyopathy (DCM) is the most frequent cause of heart failure and the leading indication for heart transplantation. Here we show that epigenetic regulator and central transcriptional instructor in adult stem cells, Bmi1, protects against DCM by repressing cardiac senescence. Cardiac-specific Bmi1 deletion induces the development of DCM, which progresses to lung congestion and heart failure. In contrast, Bmi1 overexpression in the heart protects from hypertrophic stimuli. Transcriptome analysis of mouse and human DCM samples indicates that p16(INK4a) derepression, accompanied by a senescence-associated secretory phenotype (SASP), is linked to severely impaired ventricular dimensions and contractility. Genetic reduction of p16(INK4a) levels reverses the pathology of Bmi1-deficient hearts. In parabiosis assays, the paracrine senescence response underlying the DCM phenotype does not transmit to healthy mice. As senescence is implicated in tissue repair and the loss of regenerative potential in aging tissues, these findings suggest a source for cardiac rejuvenation.
扩张型心肌病(DCM)是心力衰竭最常见的病因,也是心脏移植的主要指征。在此我们表明,成年干细胞中的表观遗传调节因子和核心转录指导因子Bmi1通过抑制心脏衰老来预防DCM。心脏特异性Bmi1缺失会诱发DCM的发展,并进展为肺淤血和心力衰竭。相反,心脏中Bmi1的过表达可免受肥厚性刺激。对小鼠和人类DCM样本的转录组分析表明,p16(INK4a)的去抑制,伴随着衰老相关分泌表型(SASP),与心室尺寸和收缩力严重受损有关。p16(INK4a)水平的基因降低可逆转Bmi1缺陷心脏的病理状态。在联体共生实验中,DCM表型背后的旁分泌衰老反应不会传递给健康小鼠。由于衰老与组织修复以及衰老组织中再生潜能的丧失有关,这些发现提示了心脏年轻化的一个来源。